RxDoctor Payments Data

Cristina Hill Jensen, MD

Gastroenterology · Sioux Falls, SDNPI 1760691794

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $39,130 of the $49,118 with a category attached, or 79.7%. Phathom Pharmaceuticals, Inc. accounts for 99.8% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $26,580, more than ten times the $47 reported in 2019. Among gastroenterology clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$49,118in general payments, 2019–2025

Across 58 payments — averaging $846.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Phathom Pharmaceuticals, Inc.$49K
  • Takeda Pharmaceuticals U.S.A., Inc.$47
  • AbbVie$36

What the payments were for

  • Speaking & faculty fees$39,13080%
  • Travel & lodging$8,49617%
  • Food & beverage$1,4913%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,118 in reported general payments places this provider in the 95th percentile of 41 gastroenterology providers in South Dakota.

See all gastroenterology providers in South Dakota

Medicare billing

Part B allowed, 2024
$146,368
Medicare patients
687
Services billed
1,281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab11$70,635
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg399$9,148
LinzessLinaclotide13$6,909
Mesalamine13$3,479
Budesonide EcBudesonide21$3,426
Budesonide DrBudesonide20$2,736
Sucralfate36$1,864
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates17$1,175
Omeprazole131$923
Gavilyte-NSodium Chloride/Nahco3/Kcl/Peg56$819
Pantoprazole Sodium65$615
Esomeprazole Magnesium14$525
Balsalazide Disodium12$476
Ondansetron OdtOndansetron214$275
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl11$211

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$36$6,90913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 41 gastroenterology providers in South Dakota.

Other gastroenterology in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →